Clinical trial
The Effect of rHuEPO on Microcircualtory Alteration in ICU Patients With Severre Sepsis and Septic Shock
NCT01087450 is registered in ClinicalTrials.gov with London Health Sciences Centre as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Effect of rHuEPO on Microcircualtory Alteration in ICU Patients With Severre Sepsis and Septic Shock
- Lead sponsor
- London Health Sciences Centre
- Phase
- Observational
- Overall status
- Terminated
- Start date
- August 12, 2009
- Completion date
- March 7, 2018
- Enrollment
- 22 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.